PlainRecalls
FDA Devices Moderate Class II Ongoing

NxTAG Respiratory Pathogen Panel +SARS-CoV-2, REF: I056C0468

Reported: October 16, 2024 Initiated: September 5, 2024 #Z-0043-2025

Product Description

NxTAG Respiratory Pathogen Panel +SARS-CoV-2, REF: I056C0468

Reason for Recall

Respiratory pathogen panel may report an elevated rate (7.6% predicted probability of occurrence) of non-specific hMPV target (human Metapneumovirus) results, risk identified predominantly in clinical samples that present positivity for another target, leading to an erroneous co-infection result, can potentially result in hMPV false positives.

Details

Units Affected
613
Distribution
U Nationwide distribution in the states of OH, CA, NC, WI, TN, TX, MI, NY, MO, FL, MA, NJ, PA, VA, AZ, IL, OK, CO, MN.
Location
Toronto

Frequently Asked Questions

What product was recalled?
NxTAG Respiratory Pathogen Panel +SARS-CoV-2, REF: I056C0468. Recalled by Luminex Molecular Diagnostics Inc. Units affected: 613.
Why was this product recalled?
Respiratory pathogen panel may report an elevated rate (7.6% predicted probability of occurrence) of non-specific hMPV target (human Metapneumovirus) results, risk identified predominantly in clinical samples that present positivity for another target, leading to an erroneous co-infection result, can potentially result in hMPV false positives.
Which agency issued this recall?
This recall was issued by the FDA Devices on October 16, 2024. Severity: Moderate. Recall number: Z-0043-2025.